# COVID-19 and Cancer Patients

> **NCT04393974** · — · COMPLETED · sponsor: **Imperial College London** · enrollment: 3820 (actual)

## Conditions studied

- Cancer
- Sars-CoV2

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04393974
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-01
- **Primary completion:** 2024-04-01
- **Final completion:** 2024-04-01
- **Target enrollment:** 3820 (ACTUAL)
- **Last updated:** 2026-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04393974

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04393974, "COVID-19 and Cancer Patients". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04393974. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*